Azithromycin attenuates Pseudomonas-induced lung inflammation by targeting bacterial proteins secreted in the cultured medium
Background: Pseudomonas aeruginosa airway infections are a major cause of morbidity and mortality in patients with Cystic Fibrosis (CF). Azithromycin improves the related clinical outcomes but its mechanisms of action remain poorly understood. We tested the hypothesis that azithromycin down-regulate...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00499/full |